Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein S22 pseudogene 1 (MRPS22P1) is a pseudogene found on human chromosome Xq21.31[4]. Unlike its parent gene MRPS22, which encodes a mitochondrial ribosomal protein essential for mitochondrial translation and cellular energy production, the MRPS22P1 locus does not encode a protein and has no known biological or pathological function[1][4]. Pseudogenes are generally regarded as non-functional segments of DNA, although, in rare cases, some pseudogenes may participate in gene regulation through non-coding RNA mechanisms (such as acting as miRNA decoys)[2]; however, there is no evidence that MRPS22P1 possesses such activity.
Not applicable. No drugs target MRPS22P1, and no mechanism of drug action is described for pseudogenes like MRPS22P1[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein S22 pseudogene 1 (MRPS22P1).